CUSIP G52694109ORD SHS CL AQ4 2025
13 filings · latest Mar 6, 2026
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Rubric Capital Management LP | 3.33M | $137.31M |
| 2 | Vanguard Group Inc | 3.11M | $128.41M |
| 3 | Baker Bros. Advisors LP | 2.83M | $116.58M |
| 4 | Tang Capital Management LLC | 2.26M | $93.22M |
| 5 | Fmr LLC | 1.64M | $67.77M |
| 6 | Morgan Stanley | 1.36M | $56.10M |
| 7 | Fairmount Funds Management LLC | 1.32M | $54.44M |
| 8 | D. E. Shaw & Co., Inc. | 1.24M | $51.22M |
| 9 |
| 4 | Jul 17, 2025 | Blackrock, Inc. | 13G/A | 1.0% | 418.2K | SEC |
| 5 | Jul 9, 2025 | Rubric Capital Management LP | 13G/A | 9.2% | 3.91M | SEC |
| 6 | May 14, 2025 | Rubric Capital Management LP | 13G/A | 8.1% | 3.38M | SEC |
| 7 | Apr 23, 2025 | Blackrock, Inc. | 13G/A | 5.4% | 2.26M | SEC |
| 8 | Apr 4, 2025 | Tang Capital Management, LLC | 13G | 5.2% | 2.18M | SEC |
| 9 | Feb 14, 2025 | Fairmount Funds Management LLC | 13G/A | 11.0% | 9 | SEC |
| 10 | Nov 14, 2024 | Fairmount Funds Management LLC | 13G/A | 7.9% | 3.20M | SEC |
See the full Schedule 13D/13G history for Kiniksa Pharmaceuticals Intl.
Unlock full history| 1.07M |
| $44.06M |
| 10 | Bnp Paribas Financial Markets | 831.8K | $34.31M |